Unbound MEDLINE

Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands. [Bioorg Med Chem] Journal article

 
TitleHybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
Author(s)Sasse BC, Mach UR, Leppaenen J, Calmels T, Stark H 
InstitutionInstitute of Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Max-von-Laue-Straße 9, 60438 Frankfurt, Germany.
SourceBioorg Med Chem 2007 Aug 25.
AbstractA series of compounds containing privileged scaffolds of the known histamine H(1) receptor antagonists cetirizine, mianserin, ketotifen, loratadine, and bamipine were synthesized for further optimization as ligands for the related biogenic amine binding dopamine D(3) receptor. A pharmacological screening was carried out at dopamine D(2) and D(3) receptors. In the preliminary testing various ligands have shown moderate to high affinities for dopamine D(3)receptors, for example, N-(4-{4-[benzyl(phenyl)amino]piperidin-1-yl}butylnaphthalen-2-carboxamide (19a) (hD(3)K(i)=0.3nM; hD(2)K(i)=703nM), leading to a selectivity ratio of 2343.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID17826096
  
Advertise on this site.